(a) Nordlinger prognostic system |
| Risk | N | No. of risk factors | 2-year survival |
| Low | 305 | 0–2 | 79% | Intermed | 738 | 3-4 | 60% | High | 230 | 5–7 | 43% |
|
|
Risk factors are (1) age > 60 years, (2) extension of primary CRC into serosa, (3) node-positive primary CRC, (4) time interval from primary CRC to CRLM < 2 years, (5) size of largest CRLM ≥ 5 cm, (6) number of CRLM ≥ 4, (7) margin less than 1 cm [16].
|
(b) Fong prognostic system |
| Clinical risk score for tumor recurrence | | Survival | | | % | | Risk factors | 1 yr | 2 yr | 3 yr | 4 yr | 5 yr | Median (months) |
| 0 | 93 | 79 | 72 | 60 | 60 | 74 | 1 | 91 | 76 | 66 | 54 | 44 | 51 | 2 | 89 | 73 | 60 | 51 | 40 | 47 | 3 | 86 | 67 | 42 | 25 | 20 | 33 | 4 | 70 | 45 | 38 | 29 | 25 | 20 | 5 | 71 | 45 | 27 | 14 | 14 | 22 |
|
|
Risk factors are (1) node-positive primary CRC, (2) time interval from primary CRC to CRLM < 1 year, (3) number of CRLM > 1, (4) size of largest CRLM > 5 cm, (5) CEA > 200 ng/mL (reproduced from [9]).
|
(c) Schindl prognostic system |
| Risk | N | Prognostic score | Median survival (months) | 5-year survival (%) |
| Good | 33 | 0–10 | 36 | 62 | Mod | 172 | 11–25 | 34 | 20 | Poor | 65 | >25 | 11 | 0 |
|
|
Prognostic score = [(4 × Dukecode) + (6 × Metcode3) + (6 × lnAlkphos) + (2 × lnCEA) − Albumin] + 22, where Dukecode indicates Dukes stage A/B (score, 0) or C (score, 1), Metcode3, 1 to 3 metastases (score, 0) or more than 3 metastases (score, 1), lnAlkphos, natural logarithmic function of the serum concentration of alkaline phosphatase (U/L), lnCEA, natural logarithmic function of the serum concentration of CEA (μg/L), and Albumin, the serum concentration of albumin (g/dL) [17].
|